Oncology Institute Inc
NASDAQ:TOI
Cash Flow Statement
Cash Flow Statement
Oncology Institute Inc
| Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||
| Net Income |
(6)
|
(11)
|
9
|
4
|
1
|
0
|
(49)
|
(61)
|
(75)
|
(83)
|
(73)
|
(72)
|
(70)
|
(65)
|
(64)
|
(66)
|
(66)
|
|
| Depreciation & Amortization |
3
|
3
|
4
|
5
|
4
|
4
|
5
|
5
|
5
|
6
|
6
|
6
|
6
|
6
|
7
|
7
|
7
|
|
| Change in Deffered Taxes |
(4)
|
(1)
|
(1)
|
(1)
|
2
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
|
| Stock-Based Compensation |
0
|
25
|
33
|
40
|
46
|
28
|
24
|
22
|
20
|
18
|
17
|
16
|
14
|
11
|
9
|
6
|
5
|
|
| Other Non-Cash Items |
(1)
|
(9)
|
(39)
|
(45)
|
(51)
|
(46)
|
2
|
13
|
33
|
39
|
26
|
22
|
18
|
14
|
18
|
25
|
29
|
|
| Cash Taxes Paid |
1
|
2
|
2
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
5
|
5
|
4
|
4
|
4
|
5
|
4
|
4
|
|
| Change in Working Capital |
(3)
|
(14)
|
(23)
|
(23)
|
(28)
|
(20)
|
(17)
|
(15)
|
(9)
|
2
|
4
|
(1)
|
12
|
18
|
24
|
24
|
6
|
|
| Cash from Operating Activities |
(10)
N/A
|
(33)
-220%
|
(50)
-53%
|
(61)
-21%
|
(71)
-18%
|
(62)
+13%
|
(60)
+2%
|
(59)
+3%
|
(46)
+21%
|
(36)
+22%
|
(37)
-1%
|
(44)
-19%
|
(35)
+21%
|
(27)
+23%
|
(16)
+41%
|
(10)
+35%
|
(24)
-132%
|
|
| Investing Cash Flow | ||||||||||||||||||
| Capital Expenditures |
(3)
|
(3)
|
(3)
|
(5)
|
(4)
|
(6)
|
(6)
|
(6)
|
(6)
|
(5)
|
(3)
|
(4)
|
(3)
|
(4)
|
(4)
|
(3)
|
(4)
|
|
| Other Items |
(1)
|
(9)
|
(8)
|
(17)
|
(104)
|
(126)
|
(106)
|
(71)
|
24
|
67
|
67
|
61
|
62
|
50
|
30
|
10
|
0
|
|
| Cash from Investing Activities |
(3)
N/A
|
(12)
-263%
|
(12)
+4%
|
(22)
-88%
|
(108)
-393%
|
(132)
-22%
|
(112)
+15%
|
(77)
+31%
|
18
N/A
|
63
+240%
|
64
+2%
|
57
-11%
|
60
+5%
|
46
-22%
|
27
-42%
|
7
-73%
|
(4)
N/A
|
|
| Financing Cash Flow | ||||||||||||||||||
| Net Issuance of Common Stock |
20
|
20
|
0
|
(9)
|
(9)
|
(8)
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
2
|
13
|
|
| Net Issuance of Debt |
(2)
|
(7)
|
(10)
|
(10)
|
101
|
106
|
106
|
106
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(20)
|
(20)
|
(20)
|
|
| Other |
0
|
141
|
140
|
138
|
137
|
(6)
|
(6)
|
(6)
|
(5)
|
(6)
|
(5)
|
(6)
|
(5)
|
(4)
|
13
|
15
|
15
|
|
| Cash from Financing Activities |
18
N/A
|
154
+764%
|
130
-16%
|
119
-8%
|
229
+92%
|
92
-60%
|
92
0%
|
100
+9%
|
(6)
N/A
|
(7)
-16%
|
(6)
+11%
|
(6)
+7%
|
(5)
+9%
|
(3)
+32%
|
(7)
-109%
|
(3)
+56%
|
8
N/A
|
|
| Change in Cash | ||||||||||||||||||
| Net Change in Cash |
4
N/A
|
109
+2 457%
|
68
-38%
|
37
-46%
|
50
+36%
|
(101)
N/A
|
(80)
+21%
|
(35)
+56%
|
(34)
+4%
|
19
N/A
|
21
+7%
|
8
-64%
|
20
+164%
|
16
-19%
|
4
-77%
|
(6)
N/A
|
(20)
-222%
|
|
| Free Cash Flow | ||||||||||||||||||
| Free Cash Flow |
(13)
N/A
|
(36)
-180%
|
(54)
-50%
|
(65)
-22%
|
(76)
-16%
|
(67)
+11%
|
(67)
+1%
|
(64)
+3%
|
(52)
+19%
|
(41)
+22%
|
(40)
+2%
|
(48)
-20%
|
(38)
+22%
|
(30)
+19%
|
(19)
+37%
|
(13)
+32%
|
(28)
-111%
|
|